Target intelligence / Profile preview

Synaptic gene expression modulators

Molecular classification
Transcription factor, Chromatin regulator, Other
01

Overview

Synaptic gene expression modulators" refers to a large and heterogenous class of molecules—including transcription factors (such as DEAF1, MEF2), chromatin modifiers (such as CLAMP), and signaling pathway components—that regulate the transcription of genes required for synapse formation, function, and plasticity in neurons[1][2]. These modulators ensure the timely and coordinated expression of hundreds of synaptic genes during neural development and in response to neuronal activity. While they are critical for proper nervous system formation and maintenance, dysregulation of these modulators can contribute to neurodevelopmental and neuropsychiatric disorders. Importantly, "synaptic gene expression modulators" as a term refers to a functionally defined group, not a specific molecular target or druggable entity[1][2]. Key clarifying points: - The term should not be treated as a canonical drug target. - For structured drug discovery and target annotations, use individual proteins (e.g., MEF2, DEAF1, CREB) rather than broad functional descriptors. - No normalized abbreviation, specific interacting drugs, or universal biomarkers exist for this category as a whole. - For target-based research, further specify the key modulator protein of interest.

Other names
Synaptic gene expression regulatorsRegulators of synaptic gene transcriptionSynaptic transcription modulators
02

Mechanism of action

Alteration of transcriptional activity; Modulation of chromatin accessibility; Activity-dependent regulation (e.g. via calcium signaling); Epigenetic modification; Feedback regulation of synapse number

03

Biological functions

Regulation of gene transcriptionControl of synaptic developmentMaintenance of synaptic functionRegulation of synaptic plasticityModulation of neurotransmitter systems
04

Disease associations

Neurodevelopmental disordersIntellectual disabilityNeurodegenerative disease (by association)Other
05

Safety considerations

Lack of specificityOff-target effectsDisruption of neuronal function

Beyond the preview

Go deeper on Synaptic gene expression modulators.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Synaptic gene expression modulators.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call